According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, obese patients receiving incretin-based therapies for weight loss should be monitored for the development of pancreatitis
Many patients report increased energy within a day or two, with weight-loss benefits developing over several weeks of consistent use
A healthcare provider can diagnose properly and recommend appropriate treatment options, including therapy, medication, or a combination
For others, doctors may recommend oral supplements or injections.
The safety findings were more informative than the efficacy data
The injections will help the body target fat deposits, especially in the liver